Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trialOfri Mosenzon, Itamar Raz, Sabina A. Murphy et al.|The Lancet Diabetes & Endocrinology|2019Cited by 673
Curalin supplement for patients with type 2 diabetes mellitusRoni Weinberg Sibony, Itamar Raz, Julio Wainstein et al.|Diabetes/Metabolism Research and Reviews|2023Cited by 1
Curalin supplement as add-on therapy for type 2 diabetes MellitusItamar Raz, Omri Segev, Ron Elul et al.|Diabetes Research and Clinical Practice|2024Cited by 0